W. E. Wick

564 total citations
15 papers, 434 citations indexed

About

W. E. Wick is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, W. E. Wick has authored 15 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in W. E. Wick's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Cancer therapeutics and mechanisms (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). W. E. Wick is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Cancer therapeutics and mechanisms (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). W. E. Wick collaborates with scholars based in United States. W. E. Wick's co-authors include David A. Preston, Robert S. Gordee and William B. Sutton and has published in prestigious journals such as Journal of Bacteriology, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

W. E. Wick

15 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. E. Wick United States	11	285	166	123	113	93	15	434
P. W. Muggleton United Kingdom	13	186 0.7×	115 0.7×	77 0.6×	144 1.3×	81 0.9×	32	562
F. Leitner United States	12	394 1.4×	259 1.6×	105 0.9×	118 1.0×	138 1.5×	29	562
G. Beskid United States	16	219 0.8×	184 1.1×	81 0.7×	186 1.6×	111 1.2×	35	531
Takeo Murakawa Japan	17	371 1.3×	208 1.3×	107 0.9×	244 2.2×	72 0.8×	36	658
M Misiek United States	11	346 1.2×	226 1.4×	85 0.7×	113 1.0×	102 1.1×	26	497
Shirley Stevens United States	5	136 0.5×	88 0.5×	108 0.9×	74 0.7×	80 0.9×	5	365
L. D. Sabath United States	12	243 0.9×	351 2.1×	166 1.3×	232 2.1×	97 1.0×	13	620
Gordon Brier United States	11	223 0.8×	112 0.7×	123 1.0×	68 0.6×	108 1.2×	19	400
E. Schrinner Germany	14	361 1.3×	275 1.7×	127 1.0×	115 1.0×	150 1.6×	36	576
MICHAEL J. BASKER United States	12	274 1.0×	244 1.5×	89 0.7×	124 1.1×	81 0.9×	35	503

Countries citing papers authored by W. E. Wick

Since Specialization

Citations

This map shows the geographic impact of W. E. Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. E. Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. E. Wick more than expected).

Fields of papers citing papers by W. E. Wick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. E. Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. E. Wick. The network helps show where W. E. Wick may publish in the future.

Co-authorship network of co-authors of W. E. Wick

This figure shows the co-authorship network connecting the top 25 collaborators of W. E. Wick. A scholar is included among the top collaborators of W. E. Wick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. E. Wick. W. E. Wick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wick, W. E., et al.. (1973). Compound 64716, a New Synthetic Antibacterial Agent. Antimicrobial Agents and Chemotherapy. 4(4). 415–420. 51 indexed citations

Wick, W. E., et al.. (1973). New Synthetic Antibacterial Compound, 1-(2-Hydroxyethyl)-3-Nitro-4-Pyrazolecarboxamide. Antimicrobial Agents and Chemotherapy. 4(3). 343–345. 10 indexed citations

Wick, W. E. & David A. Preston. (1972). Biological Properties of Three 3-Heterocyclic-Thiomethyl Cephalosporin Antibiotics. Antimicrobial Agents and Chemotherapy. 1(3). 221–234. 85 indexed citations

Wick, W. E., et al.. (1971). Cephaloglycin and Its Biologically Active Metabolite Desacetylcephaloglycin. Applied Microbiology. 21(3). 426–434. 15 indexed citations

Wick, W. E.. (1967). Cephalexin, a New Orally Absorbed Cephalosporin Antibiotic. Applied Microbiology. 15(4). 765–769. 40 indexed citations

Wick, W. E.. (1967). Cephalexin, a New Orally Absorbed Cephalosporin Antibiotic. Applied Microbiology. 15(4). 765–769. 62 indexed citations

Sutton, William B., et al.. (1966). IN VITRO AND IN VIVO LABORATORY STUDIES ON THE ANTITUBERCULOUS ACTIVITY OF CAPREOMYCIN. Annals of the New York Academy of Sciences. 135(2). 947–959. 18 indexed citations

Wick, W. E., et al.. (1965). In Vitro and In Vivo Laboratory Evaluation of Cephaloglycin and Cephaloridine. Applied Microbiology. 13(2). 248–253. 26 indexed citations

Wick, W. E., et al.. (1965). In Vitro and In Vivo Laboratory Evaluation of Cephaloglycin and Cephaloridine. Applied Microbiology. 13(2). 248–253. 56 indexed citations

10.

Wick, W. E.. (1964). INFLUENCE OF ANTIBIOTIC STABILITY ON THE RESULTS OF IN VITRO TESTING PROCEDURES. Journal of Bacteriology. 87(5). 1162–1170. 25 indexed citations

11.

Wick, W. E., et al.. (1962). IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOTHIN, A NEW BROAD SPECTRUM ANTIBIOTIC. Journal of Bacteriology. 84(6). 1292–1296. 28 indexed citations

12.

Wick, W. E., et al.. (1961). GUIDE TO ANTIBIOTIC THERAPY OF EXPERIMENTAL BACTERIAL INFECTIONS IN MICE. Journal of Bacteriology. 81(2). 233–235. 6 indexed citations

13.

Wick, W. E., et al.. (1960). Influence of inoculum size on antibiotic sensitivity patterns of Staphylococci as determined by the disc-plate method.. PubMed. 10. 145–7. 2 indexed citations

14.

Wick, W. E., et al.. (1960). Antipenicillinase serum: use in treatment of resistant staphylococcal infections in laboratory animals.. PubMed. 10. 71–7. 4 indexed citations

15.

Wick, W. E., et al.. (1957). WHITE VARIANTS DERIVED FROM STAPHYLOCOCCUS AUREUS: COMPARISONS WITH PARENT STRAINS. Journal of Bacteriology. 73(5). 685–686. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact